Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...
The provider of highly-engineered processing equipment and solutions will sell a 51% stake in the injection molding and extrusion business for $287 million.
Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it ...
(Reuters) -Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it does not already own for $25.75 apiece, a filing showed on ...
KKR increased the offer after Bain Capital said in December it could offer a tender price of 9,600 yen a share, higher than KKR's original offer. Fuji Soft's share price has more than doubled over the ...
But one BDC that has been seemingly firing on all cylinders despite the challenging economic backdrop is Bain Capital Specialty Finance (NYSE:BCSF). Over the past year, the BDC has shown some ...
Frontline will continue to be led by CEO Mitch Williams, and the current management team, who will remain significant investors in the company.
Frontline Road Safety (“Frontline” or the “Company”), the largest provider of pavement marking services in the U.S., today announced that Bain Capital has entered into a definitive ...
Bain Capital Private Equity proposed to buy the remaining shares of Surgery Partners, an ambulatory surgery center provider in which the private equity firm already has a 39% stake. Under the ...
Bain Capital and its affiliates own approximately 39% of the Company’s outstanding common stock, based on the Schedule 13D/A filing dated January 28, 2025. A Special Committee of independent ...
Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results